News
Epic Wound Care, Inc. Achieves FDA Manufacturer Registration Status
United EcoEnergy Corp.'s principal operating subsidiary, Epic Wound Care, Inc., today announced that it has successfully accomplished its manufacturer's registration. United EcoEnergy develops, manufactures and markets products and technologies in the healthcare sector.
CCS Medical to Pursue Plan of Reorganization
CCS Medical, Inc. a leading provider of medical supplies, today announced that it will pursue the Plan of Reorganization, dated as of February 9, 2010 (as may be amended, modified, and /or supplemented, the "Plan"). A hearing to consider approval of the Plan has been scheduled for March 11, 2010 with the United States Bankruptcy Court for the District of Delaware (the "Court").
Join WOCN Society As It Makes History
Healthcare professionals who specialize in wound, ostomy and/or continence care will have the opportunity to participate in a groundbreaking conference that combines the expertise of two premier wound, ostomy and continence associations, The Wound, Ostomy and Continence Nurses (WOCN) Society and The World Council of Enterostomal Therapists (WCET). The 2010 WOCN/WCET Joint Conference, Universal Focus on Patient Care, scheduled for June 12-16, 2010 in Phoenix, AZ, will highlight the most up-to-date patient care treatments, evidence-based research, and emerging techniques designed to enhance the profession. Educational offerings include sessions on the yet-to-be-released WOCN Ostomy and Pressure Ulcer Guidelines, transcultural nursing, evaluation of fecal incontinence, CMS updates and many other sessions of interest to nurses practicing in the fields of wound, ostomy and continence throughout the world. Registration is now open.
Epic Wound Care Ships Wound Care Product to Israel
United EcoEnergy Corp., announced today that its principal operating subsidiary, Epic Wound Care, Inc. has commenced shipping Epic's proprietary wound care product to the Middle East through its distributor Coreva Health Science LLC. United EcoEnergy Corp (UEEC) develops, manufactures and markets products and technologies in the healthcare sector.
SANUWAVE’s PACE Treats Severe Burns without Surgery
SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, announced that a European scientific study reporting the successful treatment of severe burns using the dermaPACE® device has been published by BURNS, the Journal of the International Society for Burn Injuries.
HEALTHPOINT To Provide Grants for Research Initiative
Healthpoint today announced it has provided research grants to the University of Florida, Gainesville, and Vanderbilt University School of Medicine to support a joint study evaluating bioburden and potential healing markers in chronic wounds. This research initiative will explore the hypothesis that bacterial biofilms are associated with the breakdown of key components on cells and in the extracellular matrix (ECM) that regulate wound healing. Professor Gregory Schultz and Dr. Joyce Stechmiller from University of Florida, and Professors Lillian Nanney and Jeffrey M. Davidson of Vanderbilt will serve as co-investigators for the study.
AALTCN joins the NPUAP as a Collaborating Organization Council Member
The American Association for Long Term Care Nursing (AALTCN) announces an important relationship with the National Pressure Ulcer Advisory Panel (NPUAP) as a Collaborating Organization Council (COC) member.
SANUWAVE’S PACE Shows Improved Skin Flap Survival Rates
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, announced that the scientific study that optimized PACE™ technology protocols for improving blood flow to ischemic skin was published in the Journal of Reconstructive Microsurgery.
Healthpoint Launches Collagenase SANTYL® Ointment in Canada
Healthpoint today announced that it will begin marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada. SANTYL® Ointment is a selective enzymatic agent indicated for debriding chronic dermal ulcers (e.g., pressure ulcers, vascular ulcers, and diabetic ulcers) and severely burned areas, and is now the only enzymatic debrider available in the Canadian market.
Healthpoint Expands Regenerative Medicine Portfolio
Healthpoint today announced its acquisition of two cell-based technologies from Intercytex Limited along with the corresponding intellectual property (including patents), validated fibroblast and keratinocyte cell banks, and related production and testing equipment. Terms of the deal were not disclosed by Healthpoint.
Recent comments
-
on Collagenase Santyl® Ointment, HealthpointThanks so much for helping me get my day going.
-
on PolyMem QuadraFoam® with Film Adhesive Border, Ferris Mfg. Corp.Thank you for commenting. If you have a specific case you'd like to share, I am sure the WoundSource...
-
on A Clinician's Guide to Skin Care and Wound Care Product IngredientsI want to say gracious for an interesting place about a something I have had an interest in for many...